|
This is an index of adverse event reports related to Aranesp (Erythropoiesis Stimulating Protein). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (507)
Cases resulting in a serious event (429)
Cases resulting in death (64)
Cases resulting in life threatening events (18)
Cases resulting in hospitalization (217)
Cases resulting in disability (22)
Cases resulting in other serious reactions (243)
Below is a sample of adverse event reports reports related to Aranesp (Erythropoiesis Stimulating Protein). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from United States on 2007-10-31
Patient: female, weighing 73.1 kg (160.8 pounds)
Adverse reactions / side effects: Myelodysplastic Syndrome, Sarcoidosis, Aplasia Pure RED Cell
Suspect drug(s):
Procrit
Indication: Anaemia of Malignant Disease
Start date: 2005-10-04
End date: 2006-02-28
Procrit
Start date: 2006-10-26
End date: 2006-10-26
Aranesp
Indication: Anaemia of Malignant Disease
Start date: 2005-05-09
End date: 2005-06-21
Aranesp
Start date: 2006-06-14
End date: 2006-07-05
Aranesp
Start date: 2007-06-17
End date: 2007-08-07
Other drugs received by patient: Ativan; Ambien
Adverse event in receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-31
Patient:
Adverse reactions / side effects: Mental Disorder, General Physical Health Deterioration, Full Blood Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Other drugs received by patient: Docetaxel; Adriamycin PFS; Cyclophosphamide
Adverse event in 60 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30
Patient: 60 year old female, weighing 75.0 kg (165.0 pounds)
Adverse reactions / side effects: Atelectasis, Pneumonia, Anaemia, International Normalised Ratio Increased, Mental Status Changes, Pancytopenia, Overdose, Narcotic Intoxication, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Erbitux
Indication: Colon Cancer Metastatic
Morphine Sulfate
Indication: Pain
Aranesp
Indication: Anaemia of Malignant Disease
Start date: 2007-02-26
End date: 2007-04-10
Camptosar
Indication: Colon Cancer Metastatic
Other drugs received by patient: Zofran
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from Finland on 2007-10-30
Patient: male
Adverse reactions / side effects: Anaemia, Aplasia Pure RED Cell
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Other drugs received by patient: Kefzol; Tavanic; Vancomycin HCL; Venofer; Dextropropoxyphene; Bisoprolol Fumarate; Dalacin; Diflucan; Isosorbide Dinitrate; Fragmin; Cephalexin; Paratabs; Calcium; Plavix; Alfacalcidol; Vitamins; RED Blood Cells
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Hepatic Failure, Disease Progression
Adverse event resulted in: hospitalization
Suspect drug(s):
Avastin
Dosage: 590 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Aranesp
Dosage: 200 a?g, prn
Indication: Anaemia
Oxaliplatin
Dosage: 160 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-02
Leucovorin
Dosage: 380 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-08-03
Fluorouracil
Dosage: 1140 mg, unk
Indication: Metastatic Neoplasm
Start date: 2005-07-18
End date: 2005-07-20
Fluorouracil
Dosage: 760 mg, unk
Start date: 2005-08-02
End date: 2005-08-03
Fluorouracil
Dosage: 1140 mg, unk
Start date: 2005-08-02
End date: 2005-08-04
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from Sweden on 2007-10-29
Patient: male
Adverse reactions / side effects: Anaemia, Aplasia Pure RED Cell
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Other drugs received by patient: Norvasc; Enalapril Maleate; Furix; Rocaltrol; Sodium Bicarbonate; Waran
Adverse event in female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from United States on 2007-10-29
Patient: female, weighing 73.1 kg (160.8 pounds)
Adverse reactions / side effects: Myelodysplastic Syndrome, Sarcoidosis, Aplasia Pure RED Cell
Suspect drug(s):
Procrit
Indication: Anaemia of Malignant Disease
Start date: 2005-10-04
End date: 2006-02-28
Procrit
Start date: 2006-10-26
End date: 2006-10-26
Aranesp
Indication: Anaemia of Malignant Disease
Start date: 2005-05-09
End date: 2005-06-21
Aranesp
Start date: 2006-06-14
End date: 2006-07-05
Aranesp
Start date: 2007-06-17
End date: 2007-08-07
Other drugs received by patient: Ativan; Ambien
Adverse event in female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from United Kingdom on 2007-10-29
Patient: female
Adverse reactions / side effects: Therapeutic Response Decreased, Anaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Other drugs received by patient: Blood, Whole
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from Germany on 2007-10-29
Patient: male, weighing 86.0 kg (189.2 pounds)
Adverse reactions / side effects: Anaemia, Aplasia Pure RED Cell, Reticulocyte Count Decreased
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Other drugs received by patient: Vitarenal; Metoprolol; Amlodipine; Ramipril; Alfacalcidol; Simvastatin; Furosemide; Doxazosin Mesylate
Adverse event in 64 year old male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from United States on 2007-10-25
Patient: 64 year old male, weighing 85.7 kg (188.5 pounds)
Adverse reactions / side effects: Enterocolitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Granisetron HCL
Indication: Drug USE FOR Unknown Indication
Capecitabine
Indication: Drug USE FOR Unknown Indication
Oxaliplatin
Indication: Drug USE FOR Unknown Indication
Aranesp
Start date: 2007-08-13
End date: 2007-08-13
Dexamethasone 0.5mg TAB
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Acetylsalicylic Acid SRT; Avastin; Iron; Ziac
Adverse event in 75 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from Japan on 2007-10-25
Patient: 75 year old female
Adverse reactions / side effects: Insomnia, Anorexia, Eczema
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: male
Adverse reactions / side effects: Lung Neoplasm Malignant
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Other drugs received by patient: Glyburide; Actos; Lipitor; Labetalol; Aspirin; Flomax; Lantus; Micardis
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: male
Adverse reactions / side effects: Febrile Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Prednisone
Dosage: text:unknown
Adriamycin PFS
Procrit
Indication: Anaemia of Malignant Disease
Aranesp
Dosage: daily dose:200mcg
Vincristine
Cytoxan
Allopurinol
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-23
Patient: male
Adverse reactions / side effects: Cerebral Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp
Indication: Dialysis
Start date: 2007-07-10
End date: 2007-07-31
Epoetin Alfa
Indication: Anaemia
Start date: 2007-01-22
End date: 2007-07-10
Other drugs received by patient: Aspirin; Bisoprolol Fumarate; Amlodipine Besylate; Rosuvastatin Calcium; Nifedipine; Isosorbide Dinitrate; Mitiglinide Calcium Hydrate; Calcium Carbonate; Losartan Potassium; Ticlopidine Hydrochloride; Lafutidine; Alfacalcidol
Adverse event in 64 year old male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a individual with unspecified qualification from United States on 2007-10-23
Patient: 64 year old male, weighing 85.7 kg (188.6 pounds)
Adverse reactions / side effects: Dehydration, Enterocolitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Decadron
Dosage: po
Administration route: Oral
Aranesp
Dosage: 500 microgm/sc
Indication: Anaemia
Start date: 2007-08-13
End date: 2007-08-13
Granisetron HCL
Oxaliplatin
Capecitabine UNK
End date: 2007-08-20
Other drugs received by patient: Avastin; Ziac; Aspirin; Iron (Unspecified)
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient: male, weighing 175.0 kg (385.0 pounds)
Adverse reactions / side effects: Abdominal Pain, Jaundice, Metastatic Neoplasm, Bile Duct Obstruction, Malignant Neoplasm Progression, Hepatic Failure, Oedema Peripheral, Abdominal Distension, Decreased Appetite, Lethargy
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Fluorouracil
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-04
Leucovorin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-03
Oxaliplatin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
Aranesp
Indication: Anaemia
Avastin
Indication: Metastatic Neoplasm
Start date: 2005-08-02
End date: 2005-08-02
Avastin
Dosage: unk
Adverse event in female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient: female
Adverse reactions / side effects: Herpes Zoster
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Adverse event in female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a individual with unspecified qualification from United States on 2007-10-23
Patient: female
Adverse reactions / side effects: Diverticulum, Vomiting, Gastritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Doxorubicin Hydrochloride
Indication: Anaemia of Malignant Disease
Procrit
Indication: Anaemia of Malignant Disease
Aranesp
Indication: Anaemia of Malignant Disease
Cyclophosphamide
Indication: Anaemia of Malignant Disease
Adverse event in receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-22
Patient:
Adverse reactions / side effects: Neutropenia, Leukopenia
Adverse event resulted in: life threatening event
Suspect drug(s):
Aranesp
Indication: Drug USE FOR Unknown Indication
Start date: 2007-09-17
End date: 2007-10-08
Cyclophosphamide
Start date: 2007-09-17
End date: 2007-10-08
Epirubicin
Start date: 2007-09-17
End date: 2007-10-08
Fluorouracil
Start date: 2007-09-17
End date: 2007-10-08
Other drugs received by patient: Nebilet; Atacand HCT; Aspirin; Cholestyramine; Levothyroxine Sodium
Adverse event in female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a pharmacist from United States on 2007-10-22
Patient: female
Adverse reactions / side effects: Renal Transplant
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Adverse event in 64 year old male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from United States on 2007-10-22
Patient: 64 year old male, weighing 85.7 kg (188.5 pounds)
Adverse reactions / side effects: Colitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Granisetron HCL
Indication: Drug USE FOR Unknown Indication
Capecitabine
Indication: Drug USE FOR Unknown Indication
Oxaliplatin
Indication: Drug USE FOR Unknown Indication
Aranesp
Start date: 2007-08-13
End date: 2007-08-13
Dexamethasone 0.5mg TAB
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Acetylsalicylic Acid SRT; Avastin; Iron; Ziac
Adverse event in 80 year old female receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from United States on 2007-10-22
Patient: 80 year old female
Adverse reactions / side effects: Syncope
Adverse event resulted in: hospitalization
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-22
Patient: male, weighing 57.2 kg (125.8 pounds)
Adverse reactions / side effects: Monocytosis, Neutrophilia, Aplasia Pure RED Cell, Thrombocytopenia, Leukocytosis, Normochromic Normocytic Anaemia, Eosinophilia
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
Other drugs received by patient: Advair Diskus 100 / 50; Prilosec; Lisinopril; Vitamin CAP; Darvocet
Adverse event in 34 year old male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from Korea, Democratic People's Republic of on 2007-10-22
Patient: 34 year old male
Adverse reactions / side effects: Aplasia Pure RED Cell
Suspect drug(s):
Aranesp
Indication: Dialysis
Start date: 2006-07-01
Epoetin Alfa
Start date: 2000-06-01
End date: 2007-05-01
Adverse event in male receiving Aranesp (Erythropoiesis Stimulating Protein)
Reported by a physician from Czech Republic on 2007-10-22
Patient: male
Adverse reactions / side effects: Aplasia Pure RED Cell
Suspect drug(s):
Aranesp (Erythropoiesis Stimulating Protein)
|
